For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Flagship Pioneering Innovations V, Inc.

USPTO Granted Patents = 32

EPO Patents = 3

Forward Citations = 46

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

David Arthur Berry (9 out of 84 patents)

Avak Kahvejian (9 out of 30 patents)

Jordi Mata-Fink (7 out of 26 patents)

4. Jonathan Barry Hurov (7 out of 7 patents)

5. Ignacio Martinez (6 out of 8 patents)

6. Barry Andrew Martin (6 out of 12 patents)

7. Maier Steve Avendano Amado (6 out of 6 patents)

8. Chengyi Jenny Shu (6 out of 6 patents)

9. John Patrick Casey, Jr (6 out of 13 patents)

10. Zachary Garo Armen (5 out of 5 patents)

11. George Huck Neubauer (5 out of 5 patents)

12. Julian Alexander Stanley (5 out of 5 patents)

13. Steven John Taylor (5 out of 5 patents)

14. Spencer Cory Peck (5 out of 6 patents)

15. John Miles Milwid (5 out of 15 patents)

32 patents: Sort by Forward Citations

1. 12496274 - Compositions and methods for compartment-specific cargo delivery (2025-12-16),

2. 12378578 - Fusosome compositions and uses thereof (2025-08-05),

3. 12209246 - Methods of genetically altering a whole plant seed (2025-01-28),

4. 12171801 - Compositions and related methods for controlling vector-borne diseases (2024-12-24),

5. 12115178 - Acylated active agents and methods of their use for the treatment of autoimmune disorders (2024-10-15),

6. 12018049 - Compositions and related methods for controlling vector-borne diseases (2024-06-25),

7. 11998610 - Conjugates and methods of using the same (2024-06-04),

8. 11974574 - Compositions and related methods for modulating endosymbionts (2024-05-07),

9. 11951154 - Compositions and methods for cell delivery (2024-04-09),

10. 11903975 - Methods and compositions relating to chondrisomes from blood products (2024-02-20),

11. 11903974 - Methods and compositions relating to chondrisomes from cultured cells (2024-02-20),

12. 11859219 - Methods of altering a target nucleotide sequence with an RNA-guided nuclease and a single guide RNA (2024-01-02),

13. 11813272 - Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease (2023-11-14),

14. 11690387 - Methods and related compositions for manufacturing food and feed (2023-07-04),

15. 11624065 - Methods and compositions for modulating gene expression (2023-04-11),

Flagship Pioneering Innovations V, Inc. is a privately-held biotechnology innovation company based in Cambridge, Massachusetts. The company focuses on inventing and launching breakthrough life sciences companies to address global challenges in healthcare, sustainability, and agriculture. Flagship Pioneering Innovations V, Inc. applies its proprietary innovation foundry model to create, develop, and nurture new ventures, providing them with the resources, expertise, and support needed to thrive and make a significant impact. With a team of experienced entrepreneurs, scientists, and professionals, the company aims to transform the way diseases are treated, crops are grown, and the world is powered.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

32 Patents

#70 in Cambridge, MA

#606 in Massachusetts

#10,245 in US

#20,091 in the World

Cambridge, MA, United States of America

Flagship Pioneering Innovations V, Inc.

Forward Citations = 46

84 inventors:

David Arthur Berry (9 out of 84 patents)

Avak Kahvejian (9 out of 30 patents)

Jordi Mata-Fink (7 out of 26 patents)

4. Jonathan Barry Hurov (7 out of 7 patents)

5. Ignacio Martinez (6 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…